…
Jayex Technology Limited develops and provides healthcare industry service technologies in Australia and the United Kingdom. The company offers Jayex Connect, a patient engagement platform that offers tools to improve the patient experience from a single patient engagement platform; patient Check-in which provides intuitive in-person and mobile patient check-in solutions; and patient calling which delivers clear healthcare messages, improve patient flow, and enhance the patient experience. The company was formerly known as Jayex Healthcare Limited and changed its name to Jayex Technology Limited in May 2021. Jayex Technology Limited was founded in 1978 and is based in Milton, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -4.09M | -6.12M | -4.20M | -0.94M | -1.04M |
| Net income | -3.93M | -7.25M | -3.72M | -0.80M | -0.96M |
| Selling general administrative | 4.88M | 4.56M | 4.59M | 3.74M | 3.77M |
| Selling and marketing expenses | 0.19M | 0.07M | 0.11M | 0.09M | 0.13M |
| Gross profit | -0.45M | 3.39M | 3.02M | 4.89M | 5.49M |
| Reconciled depreciation | - | 0.37M | 0.61M | 0.85M | 0.78M |
| Ebit | -2.74M | -1.45M | -0.83M | -0.56M | -0.66M |
| Ebitda | -2.53M | -1.08M | -0.24M | 0.29M | 0.12M |
| Depreciation and amortization | 0.21M | 0.37M | 0.59M | 0.85M | 0.78M |
| Operating income | -2.53M | -1.45M | -0.84M | -0.56M | -0.66M |
| Other operating expenses | 6.23M | 5.93M | 5.87M | 7.52M | 7.86M |
| Interest expense | 0.17M | 0.92M | 0.84M | 0.38M | 0.38M |
| Tax provision | -0.16M | -0.09M | -0.38M | -0.14M | -0.08M |
| Interest income | - | 0.92M | 0.35M | 0.03M | 0.36M |
| Net interest income | -0.17M | -0.92M | -0.84M | -0.38M | -0.38M |
| Extraordinary items | - | -1.21M | 0.10M | 0.16M | - |
| Income tax expense | -0.16M | -0.09M | -0.38M | -0.14M | -0.08M |
| Total revenue | 3.70M | 4.30M | 3.59M | 6.06M | 7.18M |
| Total operating expenses | 2.09M | 5.01M | 5.30M | 6.35M | 6.16M |
| Cost of revenue | 4.14M | 0.92M | 0.57M | 1.17M | 1.70M |
| Total other income expense net | -1.55M | -3.58M | -1.07M | 0.90M | 0.01M |
| Discontinued operations | - | -1.21M | 0.10M | 0.16M | 0.16M |
| Net income from continuing ops | -3.93M | -6.03M | -3.82M | -0.80M | -0.96M |
| Net income applicable to common shares | - | -7.25M | -3.98M | -0.80M | -0.96M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 0.50M | 2.30M | 9.98M | 12.36M | 13.54M |
| Intangible assets | - | 0.00M | 5.54M | 9.24M | 10.09M |
| Other current assets | 0.05M | 0.02M | 0.05M | 0.06M | 0.06M |
| Total liab | 7.35M | 8.63M | 8.59M | 8.98M | 9.37M |
| Total stockholder equity | -6.85M | -6.33M | 1.39M | 3.38M | 4.16M |
| Other current liab | 0.32M | 2.15M | 0.46M | 0.27M | 0.36M |
| Common stock | 28.43M | 28.11M | 28.11M | 26.86M | 26.17M |
| Capital stock | - | 28.11M | 28.11M | 26.86M | 26.17M |
| Retained earnings | -36.51M | -32.58M | -25.08M | -21.36M | -20.56M |
| Other liab | - | 0.00M | 0.16M | 0.48M | 0.65M |
| Good will | - | - | 3.64M | 5.72M | 6.06M |
| Other assets | - | 0.04M | 0.05M | 0.05M | 0.05M |
| Cash | 0.05M | 0.24M | 0.98M | 1.18M | 0.28M |
| Cash and equivalents | - | 0.24M | 0.98M | 1.18M | 0.28M |
| Total current liabilities | 6.53M | 7.42M | 5.87M | 6.76M | 5.09M |
| Current deferred revenue | 1.04M | 1.05M | 1.61M | 1.44M | 1.79M |
| Net debt | 3.53M | 5.16M | 4.34M | 3.62M | 4.30M |
| Short term debt | 2.76M | 3.45M | 2.76M | 3.06M | 0.95M |
| Short long term debt | - | 3.39M | 2.61M | 1.82M | 0.80M |
| Short long term debt total | 3.58M | 5.40M | 5.33M | 4.80M | 4.58M |
| Other stockholder equity | - | -1.87M | -0.10M | -2.13M | -1.45M |
| Property plant equipment | - | 0.05M | 0.44M | 0.32M | 0.47M |
| Total current assets | 0.50M | 0.80M | 2.12M | 2.75M | 2.92M |
| Long term investments | - | 1.45M | 1.96M | - | - |
| Net tangible assets | - | -6.33M | -4.08M | -5.86M | -5.93M |
| Net receivables | 0.22M | 0.40M | 0.84M | 1.17M | 2.24M |
| Long term debt | - | 1.21M | 2.46M | 1.72M | 3.54M |
| Inventory | 0.17M | 0.14M | 0.25M | 0.34M | 0.35M |
| Accounts payable | 2.40M | 1.82M | 1.03M | 1.99M | 1.99M |
| Accumulated other comprehensive income | 1.23M | -1.87M | -1.55M | -2.13M | -1.45M |
| Non currrent assets other | 0.00M | - | -0.10M | 0.05M | 0.05M |
| Non current assets total | 0.01M | 1.50M | 7.86M | 9.61M | 10.61M |
| Capital lease obligations | - | 0.06M | 0.26M | 0.12M | 0.24M |
| Long term debt total | - | 1.21M | 2.57M | 1.74M | 3.63M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | - | 0.43M | -1.37M | -1.37M | -1.37M |
| Change to liabilities | - | 0.00M | -0.61M | -0.39M | 0.76M |
| Total cashflows from investing activities | - | 0.43M | -0.77M | -0.27M | -1.47M |
| Net borrowings | - | -0.26M | 0.57M | 0.67M | 1.16M |
| Total cash from financing activities | 1.66M | -0.28M | 1.82M | 1.35M | 1.16M |
| Change to operating activities | - | - | 0.02M | -0.09M | 0.03M |
| Net income | -3.93M | -6.03M | -3.98M | -0.80M | -0.96M |
| Change in cash | -0.19M | -0.74M | -0.20M | 0.90M | -0.14M |
| Begin period cash flow | 0.24M | 0.98M | 1.18M | 0.28M | 0.42M |
| End period cash flow | 0.05M | 0.24M | 0.98M | 1.18M | 0.28M |
| Total cash from operating activities | -1.84M | -0.86M | -1.26M | -0.18M | 0.17M |
| Issuance of capital stock | 0.32M | - | 1.29M | 0.70M | - |
| Depreciation | - | 0.37M | 0.51M | 0.53M | 0.78M |
| Other cashflows from investing activities | - | 0.43M | 0.73M | 0.73M | 0.73M |
| Dividends paid | - | - | 1.12M | 1.06M | - |
| Change to inventory | -0.03M | 0.11M | 0.09M | 0.01M | 0.04M |
| Change to account receivables | 0.18M | 0.39M | 0.45M | 0.61M | -0.70M |
| Sale purchase of stock | - | - | -0.04M | -0.03M | - |
| Other cashflows from financing activities | 0.32M | 0.11M | 0.98M | 0.87M | 2.44M |
| Change to netincome | - | 6.02M | 2.08M | -0.38M | 0.23M |
| Capital expenditures | 0.00M | 0.00M | 0.14M | 0.27M | 1.47M |
| Change in working capital | 0.68M | 0.37M | 0.46M | 0.55M | 0.22M |
| Stock based compensation | - | - | 0.01M | -0.94M | 0.07M |
| Other non cash items | 0.70M | 4.43M | 2.07M | -0.23M | 0.15M |
| Free cash flow | -1.84M | -0.86M | -0.14M | -0.27M | -1.30M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PME Pro Medicus Ltd |
-4.52 2.18% |
202.79 | 81.98 | 106.38 | 83.13 | 43.70 | 74.38 | 95.34 |
| 4DX 4DMEDICAL Ltd |
-0.06 2.53% |
2.31 | - | - | 205.57 | 8.53 | 170.03 | -7.29 |
| CGS Cogstate Ltd |
0.12 3.30% |
3.76 | 33.80 | 27.86 | 9.59 | 6.95 | 6.35 | 19.27 |
| AYA ARTRYA Ltd |
-0.14 3.91% |
3.44 | - | - | 20505.14 | 7.00 | 16927.51 | 0.33 |
Jayex Technology Limited develops and provides healthcare industry service technologies in Australia and the United Kingdom. The company offers Jayex Connect, a patient engagement platform that offers tools to improve the patient experience from a single patient engagement platform; patient Check-in which provides intuitive in-person and mobile patient check-in solutions; and patient calling which delivers clear healthcare messages, improve patient flow, and enhance the patient experience. The company was formerly known as Jayex Healthcare Limited and changed its name to Jayex Technology Limited in May 2021. Jayex Technology Limited was founded in 1978 and is based in Milton, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael Denis Boyd ASIA, B.Com., B.Comm, C.A., CA, FAIC, Grad.Dip. | Exec. Chairman | 1966 |
| Nathan Woodard | Chief Financial Officer | NA |
| Mr. Nicholas Harper | Exec. Director of Software & Director | NA |
| Mr. Robert Hadley | Chief Exec. Officer | NA |
| Ms. Melanie Jaye Leydin B.Bus, C.A., CA | Company Sec. | 1973 |
| Mr. Robert Hadley | Chief Executive Officer | NA |
| Ms. Melanie Jaye Leydin B.Bus, C.A. | Company Secretary | 1973 |
| Mr. Robert Hadley | Chief Executive Officer | NA |
| Ms. Melanie Jaye Leydin B.Bus, C.A. | Company Secretary | 1973 |
| Mr. Robert Hadley | Chief Executive Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.